Addressing dyslipidemia is crucial to reducing the burden imposed by cardiovascular disease. However, many current statins have major limitations. Moreover, innovative treatments need to address ...

[1] It is likely that an increase in the number of people taking lipid-lowering medications – from 3.4 to 15.5% over the same time period – contributed substantially to these favorable trends.

These statins have a lower risk of hyperglycemia. Like statins, some other lipid-lowering medications can increase blood sugar levels, too. One older study linked taking niacin (vitamin B3 ...

It is estimated that about 50% of atherosclerotic cardiovascular disease is not driven by LDL-cholesterol – the target of most lipid-lowering drugs, including statins and PCSK9 inhibitors like ...

Dyslipidemia is a known risk factor for diabetic neuropathy, which suggests that lipid-lowering medications might have a preventive effect. In the general population, however, lipid-lowering ...

Alzheimer's disease, a devastating neurodegenerative condition that impacts millions globally, may have found an unexpected ...

Some antibiotics, antivirals, vaccinations and anti-inflammatory medications are linked to a reduced risk of dementia, a ...

The researchers said: 'We found that lipid-lowering drugs, particularly statins, were associated with decreased risk of 21 ...

The majority of current interventions primarily focus on treating the risk factors that cause vascular inflammatory diseases; lipid-lowering medications, blood pressure control medications ...

is approved to reduce extreme levels of cholesterol in adults with homozygous familial hypercholesterolaemia (HofH), used as an adjunctive therapy to other lipid lowering medications, and where ...